Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Maria P. López‐Lereu"'
Autor:
Julio Núñez, Miguel Lorenzo, Gema Miñana, Patricia Palau, Jose V. Monmeneu, Maria P. López‐Lereu, Jose Gavara, Víctor Marcos‐Garcés, Cesar Rios‐Navarro, Nerea Pérez, Elena deDios, Eduardo Núñez, Juan Sanchis, Francisco J. Chorro, Antoni Bayés‐Genís, Vicent Bodí
Publikováno v:
ESC Heart Failure, Vol 10, Iss 1, Pp 264-273 (2023)
Abstract Aims Traditional adverse events in chronic coronary syndrome (CCS) include atherothrombotic events but usually exclude heart failure (HF). Data are scarce about how new‐onset HF modifies mortality risk. We aimed to determine the incidence
Externí odkaz:
https://doaj.org/article/5d43c04b25724b559c44b0fb12964ce4
Autor:
Enrique Santas, Gema Miñana, Ingrid Cardells, Patricia Palau, Pau Llàcer, Lorenzo Fácila, Luis Almenar, Maria P. López‐Lereu, Jose V. Monmeneu, Juan Sanchis, Alicia M. Maceira, Antoni Bayés‐Genís, Julio Núñez, Myocardial‐IRON Investigators
Publikováno v:
ESC Heart Failure, Vol 7, Iss 6, Pp 4222-4230 (2020)
Abstract Aims The mechanisms underlying the beneficial effect of ferric carboxymaltose (FCM) in patients with heart failure (HF) and iron deficiency (ID) have not been completely characterized. The Myocardial‐IRON trial was a double‐blind, random
Externí odkaz:
https://doaj.org/article/f4d4545c9ccc421398710f875444bb3d
Autor:
Irene del Canto, Enrique Santas, Ingrid Cardells, Gema Miñana, Patricia Palau, Pau Llàcer, Lorenzo Fácila, Raquel López‐Vilella, Luis Almenar, Vicent Bodí, Maria P. López‐Lereu, Jose V. Monmeneu, Juan Sanchis, David Moratal, Alicia M. Maceira, Rafael de la Espriella, Francisco J. Chorro, Antoni Bayés‐Genís, Julio Núñez
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 7 (2022)
Background The mechanisms explaining the clinical benefits of ferric carboximaltose (FCM) in patients with heart failure, reduced or intermediate left ventricular ejection fraction, and iron deficiency remain not fully clarified. The Myocardial‐IRO
Externí odkaz:
https://doaj.org/article/a103d0209d6b45ef92b7486fbe443fbb
Autor:
Julio Núñez, Gema Miñana, Ingrid Cardells, Patricia Palau, Pau Llàcer, Lorenzo Fácila, Luis Almenar, Maria P. López‐Lereu, Jose V. Monmeneu, Martina Amiguet, Jessika González, Alicia Serrano, Vicente Montagud, Raquel López‐Vilella, Ernesto Valero, Sergio García‐Blas, Vicent Bodí, Rafael de la Espriella‐Juan, Josep Lupón, Jorge Navarro, José Luis Górriz, Juan Sanchis, Francisco J. Chorro, Josep Comín‐Colet, Antoni Bayés‐Genís
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 4 (2020)
Background Intravenous ferric carboxymaltose (FCM) improves symptoms, functional capacity, and quality of life in heart failure and iron deficiency. The mechanisms underlying these effects are not fully understood. The aim of this study was to examin
Externí odkaz:
https://doaj.org/article/e1e8273a4ca540c59dcf92120389f24a
Autor:
Julio Núñez, Miguel Lorenzo, Gema Miñana, Patricia Palau, Jose V. Monmeneu, Maria P. López‐Lereu, Jose Gavara, Víctor Marcos‐Garcés, Cesar Rios‐Navarro, Nerea Pérez, Elena de Dios, Eduardo Núñez, Juan Sanchis, Francisco J. Chorro, Antoni Bayés‐Genís, Vicent Bodí
Publikováno v:
ESC Heart Failure
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Esc Heart Failure
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Esc Heart Failure
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Aims Traditional adverse events in chronic coronary syndrome (CCS) include atherothrombotic events but usually exclude heart failure (HF). Data are scarce about how new-onset HF modifies mortality risk. We aimed to determine the incidence of HF and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96f788330c57254f96a6e26387bf78fb
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6963
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6963
Autor:
Jose Gavara, Hector Merenciano-Gonzalez, Jordi Llopis-Lorente, Tamara Molina-Garcia, Nerea Perez-Solé, Elena de Dios, Víctor Marcos-Garces, Jose V. Monmeneu, Maria P. Lopez-Lereu, Joaquim Canoves, Clara Bonanad, David Moratal, Julio Núñez, Antoni Bayés-Genis, Juan Sanchis, Francisco J. Chorro, Cesar Rios-Navarro, Vicente Bodí
Publikováno v:
Diagnostics, Vol 14, Iss 4, p 368 (2024)
We aimed to assess the correlation of cardiovascular magnetic resonance (CMR)-derived epicardial adipose tissue (EAT) with infarct size (IS) and residual systolic function in ST-segment elevation myocardial infarction (STEMI). We enrolled patients di
Externí odkaz:
https://doaj.org/article/e1f883e4a0e84717a8cf1b28c5886d00
Autor:
Héctor Merenciano-González, Víctor Marcos-Garcés, Jose Gavara, Ana Pedro-Tudela, Maria P. Lopez-Lereu, Jose V. Monmeneu, Nerea Perez, Cesar Rios-Navarro, Elena de Dios, Ana Gabaldón-Pérez, Cristina Albiach, Paolo Racugno, Clara Bonanad, Joaquim Canoves, Francisco J. Chorro, Vicente Bodi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Residual ST-segment elevation after ST-segment elevation myocardial infarction (STEMI) has traditionally been considered a predictor of left ventricular (LV) dysfunction and ventricular aneurism. However, the implications in terms of long-te
Externí odkaz:
https://doaj.org/article/e667584690d640c7a5aa59d95cfea0eb
Autor:
Víctor Marcos-Garcés, Nerea Perez, Jose Gavara, Maria P. Lopez-Lereu, Jose V. Monmeneu, Cesar Rios-Navarro, Elena de Dios, Hector Merenciano-González, Ana Gabaldon-Pérez, Ángel Ferrero-De-Loma-Osorio, Ángel Martínez-Brotons, Lourdes Bondanza, Juan Miguel Sánchez-Gómez, Cristina Albiach, Julio Nunez, Antoni Bayés-Genís, Francisco J. Chorro, Ricardo Ruiz-Granell, Vicente Bodi
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundImplantable cardioverter defibrillators (ICD) are effective as a primary prevention measure of ventricular tachyarrhythmias in patients with ST-segment elevation myocardial infarction (STEMI) and depressed left ventricular ejection fraction
Externí odkaz:
https://doaj.org/article/652b31db0f1b4fdc85f66aebc76a4128
Autor:
Filipa X. Valente, José Gavara, Laura Gutierrez, Cesar Rios-Navarro, Pau Rello, Manel Maymi, Ruben Fernandez-Galera, José V. Monmeneu, Augusto Sao-Aviles, Maria P. Lopez-Lereu, M. Teresa Gonzalez-Alujas, David Moratal, Hug Cuellar, José Barrabés, Imanol Otaegui, Artur Evangelista, Ignacio Ferreira, Vicente Bodi, José Rodriguez-Palomares
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 22, p 5261 (2021)
In acute ST-segment elevation myocardial infarction (STEMI) late gadolinium enhancement (LGE) may underestimate segmental functional recovery. We evaluated the predictive value of cardiac magnetic resonance (CMR) feature-tracking (FT) for functional
Externí odkaz:
https://doaj.org/article/2271f257a4b04e33af634253832ac3c2
Autor:
Gema Miñana, Julio Núñez, Antoni Bayés‐Genís, Elena Revuelta‐López, César Ríos‐Navarro, Eduardo Núñez, Francisco J. Chorro, Maria Pilar López‐Lereu, Jose Vicente Monmeneu, Josep Lupón, Juan Sanchis, Vicent Bodí
Publikováno v:
ESC Heart Failure, Vol 7, Iss 1, Pp 118-123 (2020)
Abstract Aims Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as a therapeutic target for reducing plasma low‐density lipoprotein cholesterol. Beyond lipid control, recent findings suggest a deleterious effect of this protein in t
Externí odkaz:
https://doaj.org/article/cedec5d271054635af5751bf32f61fc5